Larimar Therapeutics, Inc. Quarterly Return On Equity in % from Q1 2015 to Q3 2024

Taxonomy & unit
ratio: %
Description
Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested.
Summary
Larimar Therapeutics, Inc. quarterly/annual Return On Equity history and growth rate from Q1 2015 to Q3 2024.
  • Larimar Therapeutics, Inc. Return On Equity for the quarter ending September 30, 2024 was -35.9 %, a 10.1% decline year-over-year.
  • Larimar Therapeutics, Inc. annual Return On Equity for 2023 was -38.8 %, a 7.55% increase from 2022.
  • Larimar Therapeutics, Inc. annual Return On Equity for 2022 was -42 %, a 41.4% increase from 2021.
  • Larimar Therapeutics, Inc. annual Return On Equity for 2021 was -71.6 %, a 29.5% decline from 2020.
Return On Equity, Quarterly (%)
Return On Equity, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Start Date End Date
Q3 2024 -35.9 -3.28 -10.1% Jul 1, 2024 Sep 30, 2024
Q2 2024 -37.8 -7.88 -26.3% Apr 1, 2024 Jun 30, 2024
Q1 2024 -35.7 -1.55 -4.54% Jan 1, 2024 Mar 31, 2024
Q4 2023 -38.8 +3.17 +7.55% Oct 1, 2023 Dec 31, 2023
Q3 2023 -32.6 +15.7 +32.6% Jul 1, 2023 Sep 30, 2023
Q2 2023 -30 +41.5 +58.1% Apr 1, 2023 Jun 30, 2023
Q1 2023 -34.1 +38.6 +53.1% Jan 1, 2023 Mar 31, 2023
Q4 2022 -42 +29.6 +41.4% Oct 1, 2022 Dec 31, 2022
Q3 2022 -48.3 +24 +33.2% Jul 1, 2022 Sep 30, 2022
Q2 2022 -71.5 -13.4 -23.1% Apr 1, 2022 Jun 30, 2022
Q1 2022 -72.8 -22.8 -45.7% Jan 1, 2022 Mar 31, 2022
Q4 2021 -71.6 -16.3 -29.5% Oct 1, 2021 Dec 31, 2021
Q3 2021 -72.3 -6.76 -10.3% Jul 1, 2021 Sep 30, 2021
Q2 2021 -58.1 +58.8 +50.3% Apr 1, 2021 Jun 30, 2021
Q1 2021 -49.9 +2.57K +98.1% Jan 1, 2021 Mar 31, 2021
Q4 2020 -55.3 +3.22K +98.3% Oct 1, 2020 Dec 31, 2020
Q3 2020 -65.6 +1.86K +96.6% Jul 1, 2020 Sep 30, 2020
Q2 2020 -117 +23.3 +16.7% Apr 1, 2020 Jun 30, 2020
Q1 2020 -2.62K -2.5K -1995% Jan 1, 2020 Mar 31, 2020
Q4 2019 -3.27K -3.16K -2886% Oct 1, 2019 Dec 31, 2019
Q3 2019 -1.92K -1.84K -2302% Jul 1, 2019 Sep 30, 2019
Q2 2019 -140 -59.5 -73.7% Apr 1, 2019 Jun 30, 2019
Q1 2019 -125 -59.1 -89.2% Jan 1, 2019 Mar 31, 2019
Q4 2018 -110 -54.6 -99.1% Oct 1, 2018 Dec 31, 2018
Q3 2018 -80.1 -33.2 -70.8% Jul 1, 2018 Sep 30, 2018
Q2 2018 -80.7 -36.2 -81.2% Apr 1, 2018 Jun 30, 2018
Q1 2018 -66.2 -24.1 -57.3% Jan 1, 2018 Mar 31, 2018
Q4 2017 -55.1 -12.9 -30.5% Oct 1, 2017 Dec 31, 2017
Q3 2017 -46.9 +0.52 +1.1% Jul 1, 2017 Sep 30, 2017
Q2 2017 -44.5 +1.73 +3.74% Apr 1, 2017 Jun 30, 2017
Q1 2017 -42.1 +1.56 +3.57% Jan 1, 2017 Mar 31, 2017
Q4 2016 -42.2 -4.43 -11.7% Oct 1, 2016 Dec 31, 2016
Q3 2016 -47.4 -13 -37.9% Jul 1, 2016 Sep 30, 2016
Q2 2016 -46.3 -10.9 -30.9% Apr 1, 2016 Jun 30, 2016
Q1 2016 -43.7 -11.3 -35.1% Jan 1, 2016 Mar 31, 2016
Q4 2015 -37.8 Oct 1, 2015 Dec 31, 2015
Q3 2015 -34.4 Jul 1, 2015 Sep 30, 2015
Q2 2015 -35.3 Apr 1, 2015 Jun 30, 2015
Q1 2015 -32.3 Jan 1, 2015 Mar 31, 2015
* An asterisk sign (*) next to the value indicates that the value is likely invalid.